Geron Corporation Provides Update on Telomerase Activation Program

July 15, 2010 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

MENLO PARK, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq:GERN) today announced that the activities of TA Therapeutics, its joint venture with Hong Kong University of Science and Technology (HKUST), are being fully consolidated into Geron.

Twitter
LinkedIn
Facebook
Email
Print

Alliances Preclinical Asia